Resistance to lamivudine therapy: is there more than meets the eye?
Dusheiko
G
G
Centre for Hepatology and Institute for Hepatology, Royal Free and University College School of Medicine, Pond St, London HA5 1DE, UK. g.dusheiko@rfc.ucl.ac.uk
Bertoletti
A
A
D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D024882:Drug Resistance, Viral / Q000276:immunology*; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D019259:Lamivudine / Q000276:immunology / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000276:immunology / Q000627:therapeutic use*
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine